American College of Cardiology launches new campaign to increase diagnostic LDL screening

The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, “Driving Urgency in LDL Screening,” to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular disease to help clinicians identify those who need treatment in accordance with medical guidelines.

FDA accepts AstraZeneca-Daiichi Sankyo’s Dato-DXd BLA

Share this article A decision on the approval of AstraZeneca and Daiichi Sankyo’s therapy for breast cancer is expected in 2025. Credit: rafapress / Shutterstock.com.

April 3, 2024

Cost of Genomic Testing on the Minds of Many Oncologists

Patients’ insurance status and out-of-pocket (OOP) expenses figured prominently in oncologists’ use of genomic testing to guide treatment decisions, according to a national survey. About

January 17, 2024

New research on long COVID prevalence and risk factors

Early in the pandemic, many people who had SARS-Cov-2 infection or COVID-19 began to report that they couldn’t shake off their symptoms even after a

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.